EURL Publications
2023
Breman FC, Haegeman A, Krešić N, Philips W, De Regge N. Lumpy Skin Disease Virus Genome Sequence Analysis: Putative Spatio-Temporal Epidemiology, Single Gene versus Whole Genome Phylogeny and Genomic Evolution. Viruses. 2023 Jun 28;15(7):1471.
Haegeman A, De Leeuw I, Mostin L, Van Campe W, Philips W, Elharrak M, De Regge N, De Clercq K. Duration of Immunity Induced after Vaccination of Cattle with a Live Attenuated or Inactivated Lumpy Skin Disease Virus Vaccine. Microorganisms. 2023 Jan 13;11(1):210.
Haegeman A, De Leeuw I, Philips W, De Regge N. Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains. Viruses. 2023 Mar 28;15(4):870
Haegeman A, Sohier C, Mostin L, De Leeuw I, Van Campe W, Philips W, De Regge N, De Clercq K. Evidence of Lumpy Skin Disease Virus Transmission from Subclinically Infected Cattle by Stomoxys calcitrans. Viruses. 2023 May 30;15(6):1285
2022
Vandenbussche F, Mathijs E, Philips W, Saduakassova M, De Leeuw I, Sultanov A, Haegeman A, De Clercq K. Recombinant LSDV Strains in Asia: Vaccine Spillover or Natural Emergence? Viruses. 2022 Jun 29;14(7):1429.
2021
Aerts L, Haegeman A, De Leeuw I, Philips W, Van Campe W, Behaeghel I, Mostin L, De Clercq K. Detection of Clinical and Subclinical Lumpy Skin Disease Using Ear Notch Testing and Skin Biopsies. Microorganisms. 2021 Oct 19;9(10):2171
Agianniotaki EI, Chaintoutis SC, Haegeman A, De Clercq K, Chondrokouki E, Dovas CI. A TaqMan probe-based multiplex real-time PCR method for the specific detection of wild type lumpy skin disease virus with beta-actin as internal amplification control. Mol Cell Probes. 2021 Dec;60:101778.
Haegeman A, De Leeuw I, Mostin L, Campe WV, Aerts L, Venter E, Tuppurainen E, Saegerman C, De Clercq K. Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines. Vaccines (Basel). 2021 May 8;9(5):473.
Haegeman A, De Leeuw I, Saduakassova M, Van Campe W, Aerts L, Philips W, Sultanov A, Mostin L, De Clercq K. The Importance of Quality Control of LSDV Live Attenuated Vaccines for Its Safe Application in the Field. Vaccines (Basel). 2021 Sep 13;9(9):1019
Mathijs E, Vandenbussche F, Nguyen L, Aerts L, Nguyen T, De Leeuw I, Quang M, Nguyen HD, Philips W, Dam TV, Haegeman A, Van Borm S, De Clercq K. Coding-Complete Sequences of Recombinant Lumpy Skin Disease Viruses Collected in 2020 from Four Outbreaks in Northern Vietnam. Microbiol Resour Announc. 2021 Dec 2;10(48):e0089721.
Vidanović D, Tešović B, Šekler M, Debeljak Z, Vasković N, Matović K, Koltsov A, Krstevski K, Petrović T, De Leeuw I, Haegeman A. Validation of TaqMan-Based Assays for Specific Detection and Differentiation of Wild-Type and Neethling Vaccine Strains of LSDV. Microorganisms. 2021 Jun 6;9(6):1234.
2020
Mathijs E, Vandenbussche F, Ivanova E, Haegeman A, Aerts L, De Leeuw I, Van Borm S, De Clercq K.
Complete coding sequence of a Lumpy Skin Disease Virus from an outbreak in Bulgaria in 2016.
Microbiol Resour Announc. 2020 Oct 22;9(43):e00977-20.
Mathijs E, Vandenbussche F, Saduakassova M, Kabduldanov T, Haegeman A, Aerts L, Kyzaibayev T, Sultanov A, Van Borm S, De Clercq K.
Complete coding sequence of a Lumpy Skin Disease Virus strain isolated during the 2016 outbreak in Kazakhstan.
Microbiol Resour Announc. 2020 Jan 23;9(4):e01399-19.
Haegeman A, De Vleeschauwer A, De Leeuw I, Vidanovic D, Sekler M, Petrovic T, Demarez C, Lefebvre D, De Clercq K
Overview of diagnostic tools for Capripox virus infections.
Preventive Veterinary Medicine 181 (2020) 104704.
Haegeman A, De Leeuw I, Mostin L, Van Campe W, Aerts L, Vastag M, De Clercq K
An Immunoperoxidase Monolayer Assay (IPMA) for the detection of lumpy skin disease antibodies.
Journal of Virological Methods 277 (2020) 113800.
Cargnel M, Bianchini J, Welby S, Koenen F, Van der Stede Y, De Clercq K, Saegerman C.
Improving laboratory diagnostic capacities of emerging diseases using knowledge mapping.
Transbound Emerg Dis. 2020;00:1-15.
2019
Casal J, Saegerman C, Bertagnoli S, Meyer G, Ganière JP, Caufour P, De Clercq K, Jacquiet P, Hautefeuille C, Etore F, Napp S.
A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France.
PLoS One. 2019 Jan 25;14(1):e0210317.
2018
Saegerman C, Bertagnoli S, Meyer G, Ganière JP, Caufour P, De Clercq K, Jacquiet P, Hautefeuille C, Etore F, Casal J. 2018.
Risk of introduction of Lumpy Skin Disease into France through imports of cattle.
Transbound Emerg Dis. 2018 Dec 22.
Saegerman C, Bertagnoli S, Meyer G, Ganière JP, Caufour P, De Clercq K, Jacquiet P, Fournié G, Hautefeuille C, Etore F, Casal J. 2018.
Risk of introduction of lumpy skin disease in France by the import of vectors in animal truck.
PLoS One. 2018 Jun 11;13(6):e0198506.
2017
Haegeman A., De Vleeschauwer A., Mostin L., Van Campe W., Vastag M.,Tuppurainen E., De Clercq K. 2017.
Evaluation of vaccines against Lumpy Skin Disease using an optimized infection model: preliminary results.
FAO EMPRES360 Animal Health bulletin 47/2017.
Agianniotaki EI, Chaintoutis SC, Haegeman A, Tasioudi KE, De Leeuw I, Katsoulos PD, Sachpatzidis A, De Clercq K, Alexandropoulos T, Polizopoulou ZS, Chondrokouki ED, Dovas CI. 2017.
Development and validation of a TaqMan probe-based real-time PCR method for the differentiation of wild type lumpy skin disease virus from vaccine virus strains.
J Virol Methods. 249:48-57.
Tuppurainen, E.S.M, Venter, E.H., Shisler, J.L., Gari, G., Mekonnen, G.A., Juleff, N., Lyons, N.A., De Clercq, K., Upton, C., Bowden, T., Babiuk, S., Babiuk, L.A. 2017.
Capripoxvirus diseases: current status and opportunities for control.
Transbound Emerg Dis., 64(3):729-745.
Cardoen S, De Clercq K, Vanholme L, De Winter P, Thiry E, Van Huffel X (2017).
Preparedness activities and research needs to address emerging infectious animal and zoonotic diseases.
Rev. Sci. Tech. Off. Int. Epiz., 36 (2), 557-568.
Mathijs E, Vandenbussche F, Haegeman A, King A, Nthangeni B, Potgieter C, Maartens L, Van Borm S, De Clercq K. 2017.
Correction for Mathijs et al., Complete Genome Sequences of the Neethling-Like Lumpy Skin Disease Virus Strains Obtained Directly from Three Commercial Live Attenuated Vaccines.
Genome Announc. 5(6), e01657-16. doi: 10.1128/genomeA.01657-16.
Agianniotaki EI, Mathijs E, Vandenbussche F, Tasioudi KE, Haegeman A, Iliadou P, Chaintoutis SC, Dovas CI, Van Borm S, Chondrokouki ED, De Clercq K. 2017.
Complete Genome Sequence of the Lumpy Skin Disease Virus Isolated from the First Reported Case in Greece in 2015.
Genome Announc. 20;5(29), e00550-17. doi: 10.1128/genomeA.00550-17.
2016
Mathijs E, Vandenbussche F, Haegeman A, Al-Majali A, De Clercq K, Van Borm S. (2016).
Complete Genome Sequence of the Goatpox Virus Strain Gorgan Obtained Directly from a Commercial Live Attenuated Vaccine
Genome Announc. 2016 Oct 13;4(5). pii: e01113-16. doi: 10.1128/genomeA.01113-16.
A.Haegeman, K. Zro, D. Sammin, F. Vandenbussche, M. M. Ennaji, K. De Clercq (2016).
Investigation of a Possible Link Between Vaccination and the 2010 Sheep Pox Epizootic in Morocco.
Transbound Emerg Dis. 2016 Dec;63(6):e278-e287. doi: 10.1111/tbed.12342.
Vandenbussche F, Mathijs E, Haegeman A, Al-Majali A, Van Borm S, De Clercq K. (2016).
Complete Genome Sequence of Capripoxvirus Strain KSGP 0240 from a Commercial Live Attenuated Vaccine
Genome Announc. 2016 Oct 20;4(5). pii: e01114-16. doi: 10.1128/genomeA.01114-16.
2015
Agianniotaki EI, Mathijs E, Vandenbussche F, Tasioudi KE, Haegeman A, Iliadou P, Chaintoutis SC, Dovas CI, Van Borm S, Chondrokouki ED, De Clercq K. (2017).
Complete Genome Sequence of the Lumpy Skin Disease Virus Isolated from the First Reported Case in Greece in 2015.
Genome Announcements. 20;5(29). pii: e00550-17. doi: 10.1128/genomeA.00550-17.
2013
Haegeman A, Zro K, Vandenbussche F, Demeestere L, Van Campe W, Ennaji MM, De Clercq K. (2013).
Development and validation of three Capripoxvirus real-time PCRs for parallel testing.
J Virol Methods. 2013 Nov;193(2):446-51. doi: 10.1016/j.jviromet.2013.07.010. Link